资讯

Novo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive Appeal

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.
AlphaGalileo13 小时

A new book on modeling quantum phenomena is a journey into the quantum world

The recently published book by Senior Researcher Vesa Apaja from the Department of Physics at the University of Jyväskylä ...